APA (7th ed.) Citation

Cadavid, D., Balcer, L., Galetta, S., Aktas, O., Ziemssen, T., Vanopdenbosch, L., . . . Freeman, S. (2017). Safety and efficacy of opicinumab in acute optic neuritis (RENEW): A randomised, placebo-controlled, phase 2 trial. Lancet neurology, 16(3), 189-199. https://doi.org/10.1016/S1474-4422(16)30377-5

Chicago Style (17th ed.) Citation

Cadavid, Diego, et al. "Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-controlled, Phase 2 Trial." Lancet Neurology 16, no. 3 (2017): 189-199. https://doi.org/10.1016/S1474-4422(16)30377-5.

MLA (9th ed.) Citation

Cadavid, Diego, et al. "Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-controlled, Phase 2 Trial." Lancet Neurology, vol. 16, no. 3, 2017, pp. 189-199, https://doi.org/10.1016/S1474-4422(16)30377-5.